Provided by Tiger Trade Technology Pte. Ltd.

Silexion Therapeutics Corp

0.3941
-0.0049-1.23%
Post-market: 0.3752-0.0189-4.80%19:49 EDT
Volume:226.98K
Turnover:88.47K
Market Cap:2.19M
PE:-0.01
High:0.4056
Open:0.3890
Low:0.3770
Close:0.3990
52wk High:80.00
52wk Low:0.3730
Shares:5.56M
Float Shares:5.48M
Volume Ratio:0.47
T/O Rate:4.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.7456
EPS(LYR):-89.5962
ROE:-897.46%
ROA:-123.27%
PB:49.80
PE(LYR):0.00

Loading ...

Company Profile

Company Name:
Silexion Therapeutics Corp
Exchange:
NASDAQ
Establishment Date:
2008
Employees:
14
Office Location:
The Goldyne Savad Inst. of Gene Therapy,Hadassah Hebrew Univ Medical Ctr,Jerusalem,Israel
Zip Code:
9112001
Fax:
972 2 643 0982
Introduction:
Moringa Acquisition Corp does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company focuses on pursuing opportunities in technology-based businesses or industries in Israel. Moringa Acquisition Corp was incorporated in 2020 and is based in New York, New York.

Directors

Name
Position
Ilan Hadar
Chairman and Chief Executive Officer and Director
Avner Lushi
Director
Dror J. Abramov
Director
Ruth Alon
Director
Shlomo Noy
Director

Shareholders

Name
Position
Ilan Hadar
Chairman and Chief Executive Officer and Director
Mirit Horenshtein Hadar
Chief Financial Officer and Secretary
Mitchell Shirvan
Chief Scientific and Development Officer